Citigroup Maintains Buy on DexCom, Raises Price Target to $84

Benzinga Newsdesk www.benzinga.com Positive 78.8%

Neg 0% Neu 0% Pos 78.8%

Citigroup analyst Joanne Wuensch maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $79 to $84.

Comments

No comments yet. Be the first!